TAUCISIVE Trademark

Trademark Overview

On Thursday, November 25, 2021, a trademark application was filed for TAUCISIVE with the United States Patent and Trademark Office. The USPTO has given the TAUCISIVE trademark a serial number of 97143229. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, December 3, 2024. This trademark is owned by APRINOIA Therapeutics Inc.. The TAUCISIVE trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical purposes; diagnostic reagents and contrast media for medical use; contrast media for use with imaging medical equipment; imaging tracers, namely, diagnostic radiopharmaceutical agents for positron emission tomography (PET)

General Information

Serial Number97143229
Word MarkTAUCISIVE
Filing DateThursday, November 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and ServicesDiagnostic preparations for medical purposes; diagnostic reagents and contrast media for medical use; contrast media for use with imaging medical equipment; imaging tracers, namely, diagnostic radiopharmaceutical agents for positron emission tomography (PET)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAPRINOIA Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 104-0033
JP
Party NameAPRINOIA Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 104-0033
JP

Trademark Events

Event DateEvent Description
Monday, November 29, 2021NEW APPLICATION ENTERED
Tuesday, September 6, 2022ASSIGNED TO EXAMINER
Wednesday, September 14, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 14, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, September 14, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 14, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, September 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 3, 2023SOU EXTENSION 1 FILED
Tuesday, November 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 6, 2023SOU EXTENSION 2 FILED
Wednesday, December 6, 2023SOU EXTENSION 2 GRANTED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 4, 2024SOU EXTENSION 3 FILED
Tuesday, June 4, 2024SOU EXTENSION 3 GRANTED
Tuesday, December 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024SOU EXTENSION 4 GRANTED
Tuesday, December 3, 2024SOU EXTENSION 4 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

taucisive medical diagnostic media contrast imaging agents positron emission tomography radiopharmaceutical